HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

VU6019650

Also Known As:

(3R,4S)-1-(2,3-dihydro-1-benzofuran-5-ylsulfonyl)-3-fluoro-4-((1-methylimidazol-2-yl)sulfanylmethyl)piperidine

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - VU6019650: 1
  - Piperidines: 17
    - VU6019650: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzofurans: 26
      - VU6019650: 1

Experts

1.	Blobaum, Anna L: 1 article (01/2022)
2.	Boutaud, Olivier: 1 article (01/2022)
3.	Bubser, Michael: 1 article (01/2022)
4.	Capstick, Rory A: 1 article (01/2022)
5.	Carter, Trever R: 1 article (01/2022)
6.	Chang, Sichen: 1 article (01/2022)
7.	Cho, Hyekyung P: 1 article (01/2022)
8.	Conn, P Jeffrey: 1 article (01/2022)
9.	Felts, Andrew S: 1 article (01/2022)
10.	Foster, Daniel J: 1 article (01/2022)

Related Diseases

1.	Opioid-Related Disorders (Opiate Addiction) 01/01/2022 - "Development of VU6019650: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M5 Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder."

Related Drugs and Biologics

1.	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)